| Code | 2607D | ||||||||||
| MA number | 31/0407/16-S | ||||||||||
| Product Form: | tbl 60x10 mg (blis.PVC/PE/PVDC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 31 - HYPOLIPIDAEMICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 30.08.2016 |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Ezetimib Stada 10 mg_05.2022.pdf
|
| PIL: |
PIL_Ezetimib Stada 10 mg_06.2023.pdf
|
| Safety feature | Yes |
| Data update: | 02.02.2021 |
